INDV1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
INDV1 FAQ
What was Indivior PLC’s price range in the past 12 months?
Currently, no data Available
What is Indivior PLC’s market cap?
Indivior PLC’s market cap is $86.39B.
When is Indivior PLC’s upcoming earnings report date?
Indivior PLC’s upcoming earnings report date is Aug 04, 2026 which is in 8 days.
How were Indivior PLC’s earnings last quarter?
Indivior PLC released its earnings results on Apr 30, 2026. The company reported $16.687 earnings per share for the quarter, beating the consensus estimate of $11.472 by $5.215.
Is Indivior PLC overvalued?
According to Wall Street analysts Indivior PLC’s price is currently Undervalued.
Does Indivior PLC pay dividends?
Indivior PLC does not currently pay dividends.
What is Indivior PLC’s EPS estimate?
Indivior PLC’s EPS estimate is 15.45.
How many shares outstanding does Indivior PLC have?
Indivior PLC has 121,922,060 shares outstanding.
What happened to Indivior PLC’s price movement after its last earnings report?
Indivior PLC reported an EPS of $16.687 in its last earnings report, beating expectations of $11.472. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Indivior PLC?
Currently, no hedge funds are holding shares in MX:INDV1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Indivior Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$892.95 (― Downside)
$892.95 (― Downside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
141.07%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.95%
Trailing 12-Months
Company Description
Indivior PLC
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
INDV1 Company Deck
INDV1 Earnings Call
Q1 2026
0:00 / 0:00
INDV1 Stock 12 Month Forecast
Average Price Target
$892.95